Latest Insider Transactions at Nabriva Therapeutics PLC (NBRV)
This section provides a real-time view of insider transactions for Nabriva Therapeutics PLC (NBRV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Nabriva Therapeutics plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Nabriva Therapeutics plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2020
|
Gary Sender Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
32
-0.16%
|
$64
$2.42 P/Share
|
|
Nov 30
2020
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
368
-0.18%
|
$0
$0.43 P/Share
|
|
Nov 30
2020
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
628
-0.18%
|
$0
$0.43 P/Share
|
|
Nov 30
2020
|
Jennifer Schranz Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
301
-0.18%
|
$0
$0.43 P/Share
|
|
Nov 30
2020
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,211
-0.19%
|
$0
$0.43 P/Share
|
|
Nov 30
2020
|
Gary Sender Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
312
-0.15%
|
$0
$0.43 P/Share
|
|
Oct 31
2020
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
366
-0.18%
|
$0
$0.5 P/Share
|
|
Oct 31
2020
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
628
-0.17%
|
$0
$0.5 P/Share
|
|
Oct 31
2020
|
Jennifer Schranz Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
301
-0.18%
|
$0
$0.5 P/Share
|
|
Oct 31
2020
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,211
-0.19%
|
$0
$0.5 P/Share
|
|
Oct 31
2020
|
Gary Sender Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
312
-0.15%
|
$0
$0.5 P/Share
|
|
Sep 30
2020
|
Robert Crotty Gen Counsel & Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
366
-0.18%
|
$0
$0.53 P/Share
|
|
Sep 30
2020
|
Steven P. Gelone Director |
SELL
Payment of exercise price or tax liability
|
Direct |
628
-0.17%
|
$0
$0.53 P/Share
|
|
Sep 30
2020
|
Francesco Maria Lavino Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
366
-0.2%
|
$0
$0.53 P/Share
|
|
Sep 30
2020
|
Jennifer Schranz Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
301
-0.18%
|
$0
$0.53 P/Share
|
|
Sep 30
2020
|
Theodore R Schroeder Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,211
-0.19%
|
$0
$0.53 P/Share
|
|
Sep 30
2020
|
Gary Sender Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
312
-0.15%
|
$0
$0.53 P/Share
|